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Abstract The SWISSspine registry is the first mandatory
registry of its kind in the history of Swiss orthopaedics and
it follows the principle of ‘‘coverage with evidence
development’’. Its goal is the generation of evidence for a
decision by the Swiss federal office of health about reim-
bursement of the concerned technologies and treatments by
the basic health insurance of Switzerland. Recently,
developed and clinically implemented, the Dynardi total
disc arthroplasty (TDA) accounted for 10% of the
implanted lumbar TDAs in the registry. We compared the
outcomes of patients treated with Dynardi to those of
the recipients of the other TDAs in the registry. Between
March 2005 and October 2009, 483 patients with single-
level TDA were documented in the registry. The 52
patients with a single Dynardi lumbar disc prosthesis
implanted by two surgeons (CE and OS) were compared to
the 431 patients who received one of the other prostheses.
Data were collected in a prospective, observational multi-
center mode. Surgery, implant, 3-month, 1-year, and 2-year
follow-up forms as well as comorbidity, NASS and EQ-5D
questionnaires were collected. For statistical analyses, the
Wilcoxon signed-rank test and chi-square test were used.
Multivariate regression analyses were also performed.
Significant and clinically relevant reduction of low back
pain and leg pain as well as improvement in quality of life
was seen in both groups (P \ 0.001 postop vs. preop).
There were no inter-group differences regarding postop-
erative pain levels, intraoperative and follow-up compli-
cations or revision procedures with a new hospitalization.
However, significantly more Dynardi patients achieved a
minimum clinically relevant low back pain alleviation of
18 VAS points and a quality of life improvement of 0.25
EQ-5D points. The patients with Dynardi prosthesis
showed a similar outcome to patients receiving the other
TDAs in terms of postoperative low back and leg pain,
complications, and revision procedures. A higher likeli-
hood for achieving a minimum clinically relevant
improvement of low back pain and quality of life in
Dynardi patients was observed. This difference might be
due to the large number of surgeons using other TDAs
compared to only two surgeons using the Dynardi TDA,
with corresponding variations in patient selection, patient-
physician interaction and other factors, which cannot be
assessed in a registry study.
Keywords Dynardi  Total disc arthroplasty  Health
technology assessment  Registry  Outcome
Introduction
The SWISSspine registry on cervical and lumbar disc
prostheses has recently been introduced [1, 2]. Total disc
arthroplasty (TDA) is an alternative concept for the
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treatment of degenerative disc disease (DDD). However, in
an environment of increasingly scarce healthcare funds,
costly innovations are more thoroughly scrutinized
regarding their comparative effectiveness. As a govern-
mentally mandated national registry, SWISSspine assesses
aspects of safety and efficacy of TDA to complement
conventional sources of evidence in the literature. Based on
the acquired national and international results, the Swiss
Federal Office of Public Health (SFOPH) will ultimately
decide whether the Swiss basic health insurance should
reimburse this technology.
At present, five different suppliers sell five types of
lumbar TDAs in Switzerland. Since all devices are docu-
mented in the same standardized way SWISSspine offers
the possibility of benchmarking, i.e. comparing outcomes
of specific implants with pooled outcomes of the other
implants.
Dynardi (Zimmer GmbH, Winterthur, Switzerland) is a
relatively recent intervertebral disc prosthesis developed in
Switzerland, the clinical results of which have not yet been
published. The current article presents the outcomes of all
single-level Dynardi TDAs compared with all other pros-
theses in the SWISSspine data pool.
Materials and methods
SWISSspine, a governmentally mandated registry for
lumbar TDA was initiated in March 2005 and is ongoing
today. The structure and setup of the registry have been
described elsewhere [1, 3]. Currently, 46 surgeons from 32
hospitals have been contributing an average of 9–10 cases
per surgeon to the registry. A unique maneuver by Swiss
medical profession policy makers was the formation of an
expert group in the Swiss Spinal Society to decide on the
certification of spine surgeons for this procedure. All Swiss
spine surgeons who intend to perform TDAs must submit a
formal application to this group with proof of qualification
and adequate infrastructure. With this application, the
surgeons must sign a written agreement to document all
their interventions.
Documentation content and follow-up schedules
At the time of surgery, the surgeon completes primary
intervention and implant forms. The patient gives an
informed written consent for participation in the registry
along with a completed set of EQ-5D, NASS and comor-
bidity questionnaires. During follow-ups scheduled at
3 months, 1 year, and annually thereafter, the surgeon
completes follow-up questionnaires, and patients complete
EQ-5D and NASS questionnaires as before surgery.
Dynardi specifications
The Dynardi prosthesis (Dynardi Dynamic Artificial Disc
System) was developed by Zimmer GmbH in Switzerland,
and has been available on the Swiss market since April 2006.
As of October 2009, the Dynardi prostheses constituted
approximately 10% of the cases in the registry database.
The implant consists of two metal plates and a poly-
ethylene insert (Fig. 1). The cranial and caudal plates,
which are of the same size, are made of Protasul 20
(cobalt-chromium-molybdenum with a porous titanium
coating). They have a convex form and two anchor pins to
ensure solid primary fixation (Fig. 1). A unique tunnel in
each plate increases the contact surface with the bone, and
a central pin in the plate prevents luxation of the insert. The
insert is made of Sulene PE.
Statistical analysis
The Wilcoxon rank-sum test was used for comparison
between the Dynardi sample and the Data pool. For com-
parisons between baseline and follow-up examinations of
continuous variables such as pain VAS within the samples
Wilcoxon signed-rank test was used. When comparing
proportions, the v2 test was used. Confidence intervals for
group differences were computed. In the Wilcoxon test, the
Hodges–Lehmann estimator was used; in the v2 test, risk
for the proportion difference was calculated.
Multiple logistic regression models were built in order to
identify possible covariates with a significant influence on the
three outcomes, which were minimum clinically relevant
improvements (MCRI) of 18 points in low back and leg pain
and of 0.25 points on EQ-5D score [1, 4]. Device used, gender,
age at operation, preoperative pain levels, preoperative
EQ-5D score, surgical volume of center of intervention,
and pharmacologically treated depression were included as
covariates in the initial models.
Fig. 1 The image shows the Dynardi implant ( 2009 Zimmer
GmbH, Winterthur, Switzerland) consisting of two metal plates and a
polyethylene insert
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To achieve statistically stable modeling, the continuous
variables age, preoperative pain levels and preoperative
EQ-5D score were each categorized into three groups of
equivalent size. The age groups were: (1) between 19 and
38.1, (2) between 38.2 and 45.6, and (3) between 45.7 and
65 years. Three groups were created according to preop-
erative low back pain levels: (1)\70 VAS points, (2) C70
to \80 points, and (3) C80 points. Three groups were
created according to preoperative leg pain levels: (1) \50
VAS points, (2) C50 to \75 points, and (3) C75 points.
Finally, the three groups according to preoperative EQ-5D
score were: (1)\0.088 points, (2) C0.088 to\0.62 points,
and (3) C0.62 points.
Using backward elimination of covariates with
a = 0.05, a list of significant variables was received. This
level of significance was used for all analyses. All statis-
tical analyses were conducted using SAS 9.1 (SAS Institute
Inc, Cary, NC, USA).
Sample characteristics
The maximum follow-up time for both patient samples was
limited to 2.5 years to achieve homogenous follow-up
distributions. The Dynardi prosthesis was introduced to the
market 1 year after the registry was launched.
Dynardi sample
In October 2009, 56 months after registry launch, there
were 52 patients with a single-level lumbar Dynardi TDA:
37 women (71%) and 15 men (29%). The mean age at the
time of surgery for both sexes was 41.5 years (SD
8.7 years; age range for women was 24.6–55.9 years, for
men 26.2–58.1 years). Four of these patients (7.7%) had
depression and regularly took medication for it (Fig. 2).
Each of the two surgeons (working in two different hos-
pitals) implanted 26 single-level Dynardi devices.
Overall, 105 Dynardi lumbar TDA follow-up records
from 43 to 769 days postoperative were completed by the
surgeons and stored in the database. The mean follow-up
time was 1 year. There were 164 EQ-5D forms (52 pre-
operative, 112 follow-up) and 159 NASS forms (52 preop,
108 follow-up) available for evaluation of general and
disease-specific quality of life. Using follow-up data no
later than 2.5 years after surgery, 50 records could be used
for the regression analysis. In addition, 52 comorbidity
questionnaires were assessed. The 3-month, 1-year, and
2-year follow-up rates were 92, 67 and 37%, respectively.
Data pool: benchmark
There were 431 patients with single-level lumbar TDAs
other than Dynardi in the data pool. These included 250
women (58%) and 181 men (42%). The mean age at
the time of surgery was 42.0 years overall (SD 9.2 years),
41.2 years for the women (SD 9.4 years; range 18.5–
64.7 years) and 43.1 years for the men (SD 8.8 years;
range 19.6–64.7 years). Approximately 10.4% of these
patients suffered from depression and regularly took
medication for it (Fig. 2). The preoperative depression rate
of the Dynardi patients was not significantly different from
Fig. 2 Comorbidities in both patient samples
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that of the pool of patients with the other TDAs (7.7 vs.
10.4%, P = 0.58, 95% CI for the difference -5 to 10%).
Overall, 1,083 follow-up records of the pooled lumbar
TDAs were completed by surgeons from 32 to 901 days
postoperatively. The mean follow-up time was 1.1 years.
Also 1,580 (427 preoperative, 1,153 follow-up) EQ-5D
forms and 1,487 (415 preop, 1,072 follow-up) NASS forms
for evaluation of general and disease-specific quality of life
were available for evaluation. For the regression analysis,
the last available follow-up up to 2.5 years after surgery
was used resulting in inclusion of 403 records. In the
pooled group, 414 comorbidity questionnaires were asses-
sed. The 3-month, 1-year, and 2-year follow-up rates were
81, 58 and 35%, respectively.
Results
Pain relief
Pain was measured with two separate low back and leg
pain VAS on the NASS questionnaires.
Low back pain
The mean preoperative low back pain in the Dynardi
sample was 69 points (SD 15.6). At the 3-month follow-up
it was reduced to a mean of 24.4 points (SD 18.5), to 22.6
points at 1 year postoperatively (SD 24.3), and to 23.3
points at 2 years postoperatively (SD 23.2) (preop vs.
postop: P \ 0.001 for all follow-up intervals).
The mean preoperative low back pain in the data pool
was 70.4 points (SD 21.2). At the 3-month follow-up it was
reduced to a mean of 32 points (SD 26.2), and then slightly
decreased to 31.1 points at 1 year postoperatively (SD 28),
and decreased to 28 points at the 2-year follow-up (SD
25.6) (preop vs. postop: P \ 0.001 for all follow-up
intervals) (Fig. 3).
The comparison of postoperative low back pain between
Dynardi and the data pool showed no significant differ-
ences at the 3-month (P = 0.29, 95% CI 0–10 VAS
points), 1-year (P = 0.085, 95% CI 0–10 VAS points) and
2-year follow-up (P = 0.51, 95% CI -10 to 20 VAS
points). Also the comparison of low back pain relief in the
second postoperative year between Dynardi (46.5 points)
and the data pool (37.5 points) showed no significant dif-
ference (P = 0.074, 95% CI 0–20 VAS points).
Leg pain
The mean preoperative leg pain in the Dynardi sample was
55 points (SD 26.6). A reduction to 15.9 points after
3 months (SD 19.7), to 16.2 points at 1 year (SD 23.6), and
22 points at 2-year follow-up (SD 24.3) (preop vs. postop:
P \ 0.001 for all follow-up intervals) was observed
(Fig. 4).
The mean preoperative leg pain in the data pool was
54.5 points (SD 28.1). A reduction to 24.6 points after
3 months (SD 26.8), to 22.4 points at 1 year (SD 25.6) and
19.9 points at 2-year follow-up (SD 24.5) (preop vs.
postop: P \ 0.001 for all follow-up intervals) was docu-
mented (Fig. 4).
The comparison of postoperative leg pain between the
Dynardi sample and the data pool showed no significant
differences at the 3-month (P = 0.16, 95% CI 0–10 VAS
points), 1-year (P = 0.26, 95% CI 0–10 VAS points)
and 2-year follow-up (P = 0.62, 95% CI -10 to 10
VAS points). In addition, the comparison of leg pain relief
Fig. 3 Low back pain in the
Dynardi sample and in the data
pool
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between Dynardi and the data pool at the last available
follow-up (36.3 and 31.3 points, respectively) showed no
significant difference (P = 0.27, 95% CI 0–20 VAS
points).
Quality of life (QoL) improvement
Values of the EQ-5D range from 1 (best possible QoL) to
-0.6 (QoL worse than death).
Dynardi
On preoperative examination, the mean EQ-5D score was
0.37 points (SD 0.31). It improved to 0.82 points at the
three-month (SD 0.15), to 0.89 points at the 1-year (SD
0.13) and to 0.85 at the 2-year follow-up (SD 0.16) (preop
vs. postop: P \ 0.001 for all follow-up intervals). Thirteen
percent of patients indicated a preoperative QoL below
zero and postoperatively all patients indicated a QoL above
zero.
Data pool
On preoperative examination, the mean EQ-5D score was
0.32 points (SD 0.34). It improved to 0.71 points at
3-month (SD 0.29), to 0.72 points at 1-year (SD 0.3) and
further to 0.77 at 2 years postoperatively (SD 0.25) (preop
vs. postop: P \ 0.001 for all follow-up intervals). Twenty-
nine percent of patients indicated a preoperative QoL
below zero and postoperatively 5.5% of patients indicated a
QoL below zero.
The comparison of EQ-5D scores between the samples
preoperatively and at 3-month, 1-year and 2-year follow-ups
revealed significant differences for the first two follow-ups
(P = 0.29 preop, P = 0.011 3-month follow-up, P \ 0.001
1-year follow-up and P = 0.26 at 2-year follow-up) (Fig. 5).
The comparison of EQ-5D score improvement from preop-
erative to 2 years after surgery between Dynardi (0.48 points)
and the data pool (0.45 points) showed no significant differ-
ence (P = 0.14).
Factors influencing pain relief and QoL improvement
Low back pain
Among the covariates analyzed, preoperative low back
pain (P \ 0.001) had an influence on the achievement of
MCRI for low back pain, i.e. at least 18 points. This finding
was consistent with previous analyses of the SWISSspine
registry [1]. Furthermore, the patient sample (Dynardi vs.
pool; P = 0.004) had an influence on the MCRI in low
back pain.
The likelihood for the achievement of MCRI in low
back pain was 2.7 times higher (95% CI, 1.3–6.0) in the
Dynardi sample compared with the pool (Fig. 6).
Leg pain
Preoperative leg pain (P \ 0.001) had an influence on
postoperative leg pain relief. The likelihood for the
achievement of a MCRI (18 points) was 6.9 times higher
(95% CI, 4.2–11.6) if the preoperative leg pain VAS score
was between 50 and 75 points and 16.6 times higher (95%
CI, 8.7–31.6) if the preoperative score was higher than 75
points in comparison with the patients whose score was
lower than 50 points.
Fig. 4 Leg pain in the Dynardi
sample and in the data pool
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Quality of life (EQ-5D)
The preoperative EQ-5D score (P \ 0.001) and the patient
sample (Dynardi vs. pool, P = 0.007) had a significant
influence on the achievement of the MCRI in quality of
life. The likelihood of a MCRI in QoL was 2.6 times higher
(95% CI, 1.3–5.1) in the Dynardi sample compared to the
pooled group.
Pain thresholds and MCRI in low back/leg pain
and QoL
According to the previously reported results, the preoper-
ative pain ‘‘threshold-value’’ for clinically relevant low
back pain alleviation is 43.8 points [1]. There were 11.5%
of patients in the Dynardi sample and 11.1% of patients in
the data pool below this threshold preoperatively. Among
the patients who had a Dynardi, 92.2% achieved MCRI in
low back pain up to the last follow-up within 2.5 years as
opposed to 73.6% of the patients in the data pool (Fig. 6).
This difference was statistically significant (P = 0.004).
In the Dynardi sample 66.7% and in the data pool 65.7%
of patients achieved MCRI for leg pain (P = 0.89)
(Fig. 7).
In the Dynardi sample 74.5% and in the data pool 58.0%
of the patients achieved MCRI in QoL (Fig. 8). This dif-
ference was statistically significant (P = 0.024).
Complications and revisions
Three (5.8%) of the patients with a Dynardi had an intra-
operative complication compared to 3.9% in the data pool
Fig. 5 Difference in
postoperative QoL in the
Dynardi and pool patients
Fig. 6 Percentage of patients
with low back pain
improvement/worsening until
their last follow-up within
2.5 years by sample
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(Table 1) (Dynardi vs. data pool P = 0.21). There were no
re-interventions in the Dynardi sample, but 2.1% of cases
in the data pool had a re-intervention. The follow-up
complication rate was 11.5% in the patients with Dynardi
versus 21.2% in the pool but this difference failed to reach
significance (P = 0.081). The follow-up complications in
the SWISSspine lumbar cohort were recently reported [1].
Revisions with a second hospitalisation were similar
in the two samples (Dynardi vs. data pool P = 0.97)
(Table 1).
Discussion
The SWISSspine registry was instituted 4.5 years ago.
Recently, 1-year follow-up data from this registry showed
that lumbar TDA significantly reduced low back and leg
pain [1]. This pain alleviation was accompanied by a
substantial improvement in quality of life. The authors of
that report concluded that TDA demonstrated good short-
term efficacy and safety [1].
Given the rapidly increasing interest in TDA and the
incertitude regarding advantages and disadvantages of the
different prosthetic designs, benchmarking of these devices
has an undeniable appeal. The governmentally mandated
SWISSspine registry with its uniform documentation for all
implanted prostheses makes such an endeavor possible.
Previously, comparisons of different disc implants were
possible only by comparing different publications [5–9].
The study designs of these investigations, however, are
frequently quite different, resulting in difficult and inac-
curate comparisons. To the best of our knowledge, this is
the first literature report that involves benchmarking of a
spinal prosthesis against a group of others within one and
the same scientific investigational project.
One of the main limitations of such a registry is the fact
that the accuracy of the data depends on the sincerity of
each surgeon. The certification of Swiss surgeons by the
Fig. 7 Percentage of patients
with leg pain improvement/
worsening until their last
follow-up within 2.5 years by
sample
Fig. 8 Percentage of patients
with QoL improvement/
worsening until their last
follow-up within 2.5 years by
sample
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expert group of the Swiss Spinal Society as well as their
commitment to accurately document their cases is currently
the only existing indirect data quality control. Further data
quality control measures such as audits of surgeons by the
Spine Society, insurance companies or government
authorities are under consideration. A further limitation of
our registry results are the relatively low 2-year follow-up
rates. Since some patients have simply not reached the
according follow-up time yet, or because the questionnaires
often arrive with delay (as they are stored in the treating
institutions and are later sent in batches) the presented rates
are dynamic and further increasing with time. In addition,
we consider the article by Mannion et al. [10] an important
argument in demonstrating that outcomes of most spinal
procedures are quasi-final after about 3 months postoper-
atively. Hence, the 3-month and 1-year follow-up data
should be sufficient in estimating the clinical outcomes
after lumbar TDA, given that the prosthesis maintains a
proper function. Furthermore, the 1- and 2-year follow-up
rates of SWEspine, the Swedish spinal registry, are about
55–65% (personal communication) and SWISSspine is
well within that range with its 1-year follow-ups.
There is a constantly growing demand by regulatory
agencies and health care payers for evidence-based justi-
fication of medical procedures and devices. Randomized
controlled trials, which provide level I evidence, are
often unfeasible due to ethical aspects, organizational
complexity or cost issues. Consequently, the utilization of
the simpler and less expensive register studies is on the
rise.
Among the five TDA types currently used in the
SWISSspine registry, the Dynardi prosthesis was selected
for a comparison with the data pool because this new
implant was recently developed in Switzerland and its
results have not yet been published. Furthermore, the
implant accounts for about 10% of cases in the registry and
was therefore suitable for rigorous statistical analysis.
Regarding demographic characteristics and preoperative
clinical status, the 52 patients with the Dynardi TDA were
similar to the patients in the data pool. Both samples had
the same mean age at operation of 42 years, but there were
13% less women in the data pool. The rate of patients with
pharmacologically treated depression in both samples was
comparable. There was only 1 month difference in average
follow-up time.
There was no significant difference between the Dynardi
group and the patient pool in terms of postoperative
low back and leg pain alleviation. However, the Dynardi
patients had a higher likelihood for the achievement
of MCRI in low back pain and QoL than did the other
patients.
Postoperative low back pain and QoL were lower,
respectively, better, in the Dynardi sample, and this rela-
tion remained stable until the second postoperative year.
The values for QoL at the 3-month and 1-year follow-ups
were even significantly better in the Dynardi sample.
Postoperative leg pain in Dynardi patients was better at the
early stages but slightly worsened (6 points from 3-month
to 2-year follow-up) and reached values similar to other
patients with a 2-year follow-up.
The Dynardi sample did not have significantly different
rates of intraoperative and follow-up complications or
revisions with a new hospitalisation than the pooled group.
However, there were no re-interventions within the same
hospital stay in the Dynardi sample. Thus, the Dynardi
prosthesis seems to be at least as safe as other prostheses in
the registry.
The higher likelihood for Dynardi patients in achieving
MCRI in low back pain and QoL are findings with no
obvious technical explanation. They are probably not
related to the prosthesis itself. The higher rate of female
patients is a possible factor but the regression analysis had
not found patient sex as a covariate with significant influ-
ence on QoL or low back pain improvement. Another
possible factor may be the higher percentage of patients
with a pharmacologically treated depression in the data
pool, a factor that was previously reported to have an
influence on QoL [1]. However, that difference was not
significant. In the first evaluation, pharmacologically trea-
ted depression was a significant covariate; however,
Table 1 The table shows complications and revisions in both sam-
ples (patient based rates)
Dynardi Data pool
Intraoperative complications (%) 5.8 3.9
Blood vessel injury 3 13
Sintering of implant 0 1
Urethra injury 0 1
Vertebral body injury 0 1
Dura lesion 0 1
Revision during hospitalization (%) 0 2.1
Follow-up complications (%) 11.5 21.2
Revision with a 2nd hospitalization (%) 3.8 3.7
Dorsal spondylodesis 1 4
Ventral spondylodesis 0 4
Diam stabilization 0 2
Implant removal 0 2
Lumbar pain 0 2
Decompression 1 1
Abscess revision 0 1
Implant failure 0 1
Wound revision 0 1
Not specified 0 1
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a slight tendency of convergence of postoperative EQ score
curves for depressive and non-depressive patients was
observed [1].
The preoperative medication analysis (not reported)
showed that surgeons in the pooled group operated on
patients with a two times higher percentage of morphine
intake as the Dynardi patients, though the preoperative pain
levels were very similar. This may represent patients with
more chronic pain in the pool or with a higher pain per-
ception, which also remains after surgery. The duration of
symptoms was unfortunately not recorded as part of the
registry protocols. The physician skills and the patient–
physician interaction with the resulting compliance, social
and work circumstances, education, large number of sur-
geons using other TDAs compared to only two using the
Dynardi TDA are further possible factors which could have
influenced the outcomes and which we could not assess in
the dataset. The satisfaction not only with pain relief but
also with the treating physician and even the hospital ser-
vice may be responsible for the better short term QoL in the
Dynardi sample.
Regarding the higher likelihood of Dynardi patients for
achieving the MCRI in low back pain, we assume that
predominantly patient selection was responsible. It is the
general consensus that patient selection is the primary key
in achieving a favorable outcome [11, 12]. The proportion
of patients with a low back pain MCRI in the Dynardi
group compared with that in the pool and in the previous
analysis [1] impressively demonstrates the potential of
TDA if the indication is well made.
Published total complication rates range between 3 and
50% and those in SWISSspine (between 4 and 21%) are
relatively low [13]. A possible explanation is the frame-
work of SWISSspine where only surgeons with a proven
expertise in spinal surgery received certification for the
intervention. In addition, there may have been benefits
from advancements in instrumentation and surgical
approach as well as surgical techniques that the first
movers of the technology did not have.
As opposed to cervical disc prostheses, mid- and long-
term outcomes of the lumbar implants have been under
observation for many more years. Nevertheless, long-term
outcomes are still rarely reported [9]. The few available
investigations are rather critical in their conclusions as
opposed to the reported more promising mid- and short-
term results [13]. Further investigations are undoubtedly
needed. The current analysis cannot yet shed light onto
long-term results of lumbar TDA but SWISSspine registry
results are constantly updated and monitored and a special
5-year follow-up study is under preparation. Until then
short-term outcomes of yet another new implant, the
Dynardi lumbar TDA, can be considered equivalent to the
other models on the market.
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